These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 20950225)

  • 1. TCP modelling - why is it important?
    Carlone M; Nahum A; Stavrev P
    Acta Oncol; 2010 Nov; 49(8):1205. PubMed ID: 20950225
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimum parameters in a model for tumour control probability, including interpatient heterogeneity: evaluation of the log-normal distribution.
    Keall PJ; Webb S
    Phys Med Biol; 2007 Jan; 52(1):291-302. PubMed ID: 17183142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From cell population models to tumor control probability: including cell cycle effects.
    Hillen T; de Vries G; Gong J; Finlay C
    Acta Oncol; 2010 Nov; 49(8):1315-23. PubMed ID: 20843174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships.
    El Naqa I; Suneja G; Lindsay PE; Hope AJ; Alaly JR; Vicic M; Bradley JD; Apte A; Deasy JO
    Phys Med Biol; 2006 Nov; 51(22):5719-35. PubMed ID: 17068361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of hypoxia on the theoretical modelling of tumour control probability.
    Daşu A; Toma-Daşu I; Karlsson M
    Acta Oncol; 2005; 44(6):563-71. PubMed ID: 16165915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia as a determinant factor in radiotherapy? Where are we?
    Guichard M
    BJR Suppl; 1992; 24():142-5. PubMed ID: 1290689
    [No Abstract]   [Full Text] [Related]  

  • 7. Analytical investigation of the possibility of parameter invariant TCP-based radiation therapy plan ranking.
    Stavreva N; Nahum A; Markov K; Ruggieri R; Stavrev P
    Acta Oncol; 2010 Nov; 49(8):1324-33. PubMed ID: 20950227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining the validity of Poissonian models against the birth and death TCP model for various radiotherapy fractionation schemes.
    Horas JA; Olguín OR; Rizzotto MG
    Int J Radiat Biol; 2010 Aug; 86(8):711-7. PubMed ID: 20586544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer simulation of tumour control probabilities after irradiation for varying intrinsic radio-sensitivity using a single cell based model.
    Harting C; Peschke P; Karger CP
    Acta Oncol; 2010 Nov; 49(8):1354-62. PubMed ID: 20843178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCP and NTCP in preclinical and clinical research in Europe.
    Baumann M; Petersen C; Krause M
    Rays; 2005; 30(2):121-6. PubMed ID: 16294904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCP and NTCP: a basic introduction.
    Baumann M; Petersen C
    Rays; 2005; 30(2):99-104. PubMed ID: 16294901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted radionuclide therapy: theoretical study of the relationship between tumour control probability and tumour radius for a 32P/33P radionuclide cocktail.
    Lechner A; Blaickner M; Gianolini S; Poljanc K; Aiginger H; Georg D
    Phys Med Biol; 2008 Apr; 53(7):1961-74. PubMed ID: 18354241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell-based computer simulation of the oxygen-dependent tumour response to irradiation.
    Harting C; Peschke P; Borkenstein K; Karger CP
    Phys Med Biol; 2007 Aug; 52(16):4775-89. PubMed ID: 17671335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A general tumour control probability model for non-uniform dose distributions.
    González SJ; Carando DG
    Math Med Biol; 2008 Jun; 25(2):171-84. PubMed ID: 18515259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour control probability (TCP) for non-uniform activity distribution in radionuclide therapy.
    Uusijärvi H; Bernhardt P; Forssell-Aronsson E
    Phys Med Biol; 2008 Aug; 53(16):4369-81. PubMed ID: 18660558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor control probability for tumor therapy with beta radionuclide interstitial injection.
    Chen Y; Geng J; Tian J; He Y; Chen S
    Biomed Mater Eng; 2004; 14(3):333-5. PubMed ID: 15299245
    [No Abstract]   [Full Text] [Related]  

  • 17. Normal tissue complication probability modelling of tissue fibrosis following breast radiotherapy.
    Alexander MA; Brooks WA; Blake SW
    Phys Med Biol; 2007 Apr; 52(7):1831-43. PubMed ID: 17374914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe hypofractionation: non-homogeneous tumour dose delivery can counteract tumour hypoxia.
    Ruggieri R; Naccarato S; Nahum AE
    Acta Oncol; 2010 Nov; 49(8):1304-14. PubMed ID: 20500031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical heterogeneity and tumor control probability.
    Eisbruch A
    Acta Oncol; 2010 Nov; 49(8):1385-7. PubMed ID: 20500028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between the ideal reference dose level and the actual reference dose level from clinical 3D radiotherapy treatment plans.
    Bufacchi A; Arcangeli G; delle Canne S; Malatesta T; Capparella R; Fragomeni R; Marmiroli L; Begnozzi L
    Radiother Oncol; 2009 Jul; 92(1):68-75. PubMed ID: 19328571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.